News Warner Logo

News Warner

Tool detects hidden signs of consciousness after brain injury

Tool detects hidden signs of consciousness after brain injury

  • Researchers have developed an AI tool called SeeMe that detects hidden signs of consciousness after brain injury, which can identify patients who are conscious but unable to show it up to four days earlier than traditional clinical exams.
  • The tool uses high-resolution video and computer vision to measure involuntary facial reactions to verbal commands, providing a non-invasive and inexpensive solution for detecting cognitive motor dissociation (CMD), a diagnostic blind spot in neurology and critical care.
  • Studies have shown that SeeMe can significantly improve patient outcomes, with patients who received early detection by the tool being more likely to regain consciousness and show better functional outcomes at discharge.
  • The development of SeeMe addresses a significant gap in current medical practices, where standard bedside tests are not sensitive enough to detect CMD, leading to misdiagnosis and delayed treatment for patients who may otherwise recover.
  • The researchers envision integrating SeeMe into standard ICU practice, combining it with EEG and other data streams to create a multi-modal consciousness monitoring platform, which could revolutionize patient care and rehabilitation efforts in the future.

A hospital patient's hand sits on top of covers while hooked up to a finger monitor.

A new study provides clinicians with data about the path to consciousness after traumatic brain injury.

The research may help pave the way for more personalized and effective patient care strategies in critical care and rehabilitation settings.

Every year, thousands of brain-injured patients are labeled as “unresponsive” in hospitals across the United States. Yet new research reveals that up to one quarter of these individuals may be conscious but just unable to show it.

This disconnect, known as cognitive motor dissociation (CMD), represents one of the most urgent diagnostic blind spots in neurology and critical care.

To address this problem, Mofakham and Mikell developed a first-of-its-kind artificial intelligence (AI) tool called SeeMe, which detects signs of covert consciousness by analyzing microscopic facial movements invisible to the naked eye. Their findings suggest that SeeMe can identify signs of awareness four-to-eight days earlier than traditional clinical exams.

The work directly addresses the central dilemma outlined in a landmark 2024 study in The New England Journal of Medicine by Bodien et al., which found that 15 to 25% of patients diagnosed as unresponsive in the intensive care unit (ICU) may retain high-level brain function, but standard bedside tests are not sensitive enough to detect it. This misdiagnosis delays treatment and rehabilitation for patients who may otherwise recover.

“We developed SeeMe to fill the gap between what patients can do and what clinicians can observe,” says Mofakham, senior author of the study, associate professor and vice chair of research for the neurosurgery department, and an assistant professor in the electrical and computer engineering department in the College of Engineering and Applied Sciences at Stony Brook University.

“Just because someone can’t move their limbs or speak doesn’t mean they aren’t conscious. Our tool uncovers those hidden physical efforts by patients to show they are conscious.”

In a clinical study of 37 patients with acute brain injury and coma, SeeMe used high-resolution video and computer vision to measure involuntary facial reactions to verbal commands like “open your eyes” or “show me a smile.” These subtle responses, typically undetectable by doctors or nurses, were recorded and analyzed using machine learning.

In most of this patient cohort, SeeMe detected purposeful movement up to four days before the clinical care team recognized physical movements by the patients.

“This kind of work shows the future of medicine lies at the intersection of disciplines, as we begin to see more applications of AI and engineering in medicine. With such an approach, we aim to turn complex data into tools that can help doctors make faster and better decisions for patients when every hour counts,” Mofakham says.

Additionally, the patients from the study with early SeeMe-detected responses were significantly more likely to regain consciousness and show better functional outcomes at discharge.

“This is not just a new diagnostic tool, it’s a potential prognostic marker,” says Mikell, neurosurgeon, co-lead investigator, and clinical associate professor and vice chair for the neurosurgery department.

“Families often ask us how long it will take for a loved one to wake up, or if they ever will. This study helps us answer those questions with more confidence, grounded in data, not just experience or instinct,” explains Mikell.

“We can use this information to personalize care, guide families, and optimize rehabilitation efforts.”

The authors also suggest the ethical implications are profound with traumatic brain injury (TBI) patients and recovery. Misdiagnosis of unresponsive states can lead to inappropriate withdrawal of care, limited access to neurorehabilitation and missed windows for therapy.

The Bodien et al. study stressed the urgent need for objective tools to detect CMD at the bedside, tools that don’t require expensive imaging or invasive procedures. SeeMe is one solution as it is noninvasive, inexpensive, and scalable, according to Mofakham and Mikell. The system requires only a camera and open-source software, making it viable even in resource-constrained hospitals and ICUs.

As SeeMe moves toward larger clinical trials and potential regulatory approval, the research team envisions integrating the tool into standard ICU practice, combining it with EEG and other data streams to create a multi-modal consciousness monitoring platform. They also believe that SeeMe stands as a powerful example of how AI can restore independence to patients by letting them speak without words.

The research appears in Nature Communications Medicine.

The work for both studies was funded by multiple institutional seed grants that support the ongoing collaboration between the neurosurgery and electrical and computer engineering departments at Stony Brook University.

Source: Stony Brook University

The post Tool detects hidden signs of consciousness after brain injury appeared first on Futurity.

link

Q. What is cognitive motor dissociation (CMD) in the context of traumatic brain injury?
A. CMD represents a disconnect between a patient’s high-level brain function and their inability to show it, leading to misdiagnosis as unresponsive.

Q. How does SeeMe detect signs of covert consciousness?
A. SeeMe uses artificial intelligence (AI) to analyze microscopic facial movements invisible to the naked eye, detecting purposeful movement up to four days before clinical care teams recognize physical responses.

Q. What is the significance of SeeMe in addressing the diagnostic blind spot in neurology and critical care?
A. SeeMe can identify signs of awareness four-to-eight days earlier than traditional clinical exams, helping clinicians detect cognitive motor dissociation and provide more personalized and effective patient care strategies.

Q. How does SeeMe compare to traditional bedside tests in detecting signs of consciousness?
A. SeeMe detects signs of awareness four-to-eight days earlier than traditional clinical exams, which are not sensitive enough to detect it.

Q. What is the potential prognostic value of SeeMe in traumatic brain injury patients?
A. The study suggests that patients with early SeeMe-detected responses were significantly more likely to regain consciousness and show better functional outcomes at discharge.

Q. How does SeeMe address the ethical implications of misdiagnosis in TBI patients?
A. Misdiagnosis can lead to inappropriate withdrawal of care, limited access to neurorehabilitation, and missed windows for therapy; SeeMe aims to provide a more objective tool for detecting cognitive motor dissociation.

Q. What are the technical requirements for using SeeMe?
A. The system requires only a camera and open-source software, making it noninvasive, inexpensive, and scalable.

Q. How does SeeMe envision being integrated into standard ICU practice?
A. The research team envisions integrating SeeMe with EEG and other data streams to create a multi-modal consciousness monitoring platform.

Q. What is the potential impact of SeeMe on restoring independence to patients with TBI?
A. By detecting signs of awareness, SeeMe can let patients speak without words, potentially restoring their independence.